Reliability of patient‐reported outcome measures: Hemorrhage, anticoagulant, antiplatelet medication use
نویسندگان
چکیده
منابع مشابه
Anticoagulant and antiplatelet medications.
CRITICALCARENURSE Vol 26, No. 3, JUNE 2006 19 2. Paradiso-Hardy FL, Madan M, Radhakrishnan S, Hurden S, Cohen EA. Severe thrombocytopenia possibly related to readministration of eptifibatide. Catheter Cardiovasc Interv. September 2001;54:63-67. 3. Hongo RH, Brent BN. Association of eptifibatide and acute profound thrombocytopenia. Am J Cardiol. 2001;88:428-431. 4. Yoder M, Edwards RF. Reversibl...
متن کاملPostthrombolytic Antiplatelet Use for Patients with Intercerebral Hemorrhage without Extensive Parenchymal Involvement Does Not Worsen Outcome
BACKGROUND AND PURPOSE It is unclear whether postthrombolytic antiplatelet (AP) therapy after thrombolytic-related hemorrhage without extensive parenchymal involvement (THEPI) affects the clinical outcome. This study explored whether AP administration in patients with THEPI affects short- and long-term outcomes. METHODS All of the data for this study were collected from the Thrombolysis Imple...
متن کاملA New Generation of Antiplatelet, and Anticoagulant Medication and the Implications for the Dental Surgeon.
The management of dental patients taking either antiplatelet medication, anticoagulant medication or both has been well established in the previous literature. Recently, new generations of drugs have emerged which are becoming increasingly common, including direct thrombin inhibitors, factor X inhibitors and a new class of oral thienopyridines. The implications of these drugs for the dental sur...
متن کاملRisk of Intracranial Hemorrhage in Ground-level Fall With Antiplatelet or Anticoagulant Agents.
OBJECTIVES Anticoagulant and antiplatelet medications are known to increase the risk and severity of traumatic intracranial hemorrhage (tICH), even with minor head trauma. Most studies on bleeding propensity with head trauma are retrospective, are based on trauma registries, or include heterogeneous mechanisms of injury. The goal of this study was to determine the rate of tICH from only a commo...
متن کاملEpistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study.
OBJECTIVES Epistaxis can be caused or exacerbated by anticoagulant and antiplatelet therapy. This prospective study assessed the prevalence of epistaxis in patients taking anticoagulant and antiplatelet medication, and monitored differences in patients' clinical courses. METHOD Prospective data were collected for consecutive patients referred with epistaxis from the emergency department over ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Research and Practice in Thrombosis and Haemostasis
سال: 2021
ISSN: 2475-0379,2475-0379
DOI: 10.1002/rth2.12501